We provide evidence supporting blood NfL levels as the best prognostic liquid biomarker for the presence of CALD-suggestive lesions in the brain of both childhood/adolescent and adult X-ALD patients. The gene discussed is NEFL; the disease is X-linked adrenoleukodystrophy.